View in EDS HTML Full Text PDF Full Text

Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density.

Saved in:
Bibliographic Details
Title: Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density.
Authors: Voskaridou E; Thalassaemia and Sickle Cell Disease Reference Centre, Laikon General Hospital, Athens, Greece., Ntanasis-Stathopoulos I; Department of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 80 Vas. Sofias Avenue, 11528, Athens, Greece., Christoulas D; Department of Haematology, 251 General AirForce Hospital, Athens, Greece., Dimopoulou M; Thalassaemia and Sickle Cell Disease Reference Centre, Laikon General Hospital, Athens, Greece., Komninaka V; Thalassaemia and Sickle Cell Disease Reference Centre, Laikon General Hospital, Athens, Greece., Repa K; Thalassaemia and Sickle Cell Disease Reference Centre, Laikon General Hospital, Athens, Greece., Papatheodorou A; Department of Medical Research, 251 General AirForce Hospital, Athens, Greece., Terpos E; Department of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 80 Vas. Sofias Avenue, 11528, Athens, Greece. eterpos@med.uoa.gr.
Source: Annals of hematology [Ann Hematol] 2019 Jul; Vol. 98 (7), pp. 1583-1592. Date of Electronic Publication: 2019 Apr 30.
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0584
DOI:10.1007/s00277-019-03695-x